Core Viewpoint - Tempus AI, Inc. is facing a securities class action lawsuit for failing to disclose material information during the class period, which has led to a significant drop in its stock price [3][5]. Group 1: Lawsuit Details - Investors have until August 12, 2025, to file lead plaintiff applications if they purchased shares between August 6, 2024, and May 27, 2025 [1]. - The lawsuit is pending in the United States District Court for the Northern District of Illinois [1]. - The case is identified as Shouse v. Tempus AI, Inc., et al., No. 25-cv-06534 [5]. Group 2: Allegations Against Tempus - Tempus and its executives are accused of violating federal securities laws by not disclosing critical information during the class period [3]. - Spruce Point Capital Management reported several issues, including overstated AI capabilities, a history of executives cashing out before losses, and aggressive accounting practices [4]. - Concerns were raised regarding the AstraZeneca and Pathos AI deal, as well as a recent revision in financial guidance indicating weaknesses in core operations [4]. Group 3: Market Reaction - Following the news of the lawsuit and allegations, Tempus' share price fell by $12.67, or 19.23%, from $65.87 to $53.20 on May 28, 2025 [5].
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM